UTokyo IPC (investor - Corporate Investor)
See something wrong or missing? Let us know
Offices:Tokyo
UTokyo IPC is actively investing the startups who wish to connect to the University of Tokyo.
Average round investment:33.67M USD
Average number per year:1.0
Distribution:
2026 (1)2022 (1)2021 (1)
Portfolio companies:
Storm Therapeutics
VividQ
Storm Therapeutics
VividQ
Mostly invests in:
United Kingdom (3)
Biotech (2)
United Kingdom (3)
Biotech (2)
3 tracked investments in:
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Investors with similar profile to UTokyo IPC
| Name | Criteria | |
|---|---|---|
![]() |
Arcadia Holdings srl
83%
|
|
![]() |
Cantor Fitzgerald Private Clients
83%
|
|
![]() |
CR-CP Life Science Fund
83%
|
|
![]() |
Kathaka
83%
|
|
![]() |
SAIC Capital
83%
|
|
![]() |
Space Angels
83%
|
|
![]() |
Van Tuyl Companies
83%
|
|
![]() |
Rockspring
83%
|
|
![]() |
Mayo Clinic
83%
|
|
![]() |
Rick Klausner
83%
|
|





Belgium
Netherlands
Austria
Germany
Switzerland
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
France
Portugal
Spain